Anti-eEF-2K monoclonal antibody

Pre-made anti-eEF-2K monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to eEF-2K/EEF2K products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T92494-Ab-1/ GM-Tg-hg-T92494-Ab-2Anti-Human eEF-2K/EEF2K monoclonal antibodyHuman
GM-Tg-rg-T92494-Ab-1/ GM-Tg-rg-T92494-Ab-2Anti-Rat eEF-2K/EEF2K monoclonal antibodyRat
GM-Tg-mg-T92494-Ab-1/ GM-Tg-mg-T92494-Ab-2Anti-Mouse eEF-2K/EEF2K monoclonal antibodyMouse
GM-Tg-cynog-T92494-Ab-1/ GM-Tg-cynog-T92494-Ab-2Anti-Cynomolgus/ Rhesus macaque eEF-2K/EEF2K monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T92494-Ab-1/ GM-Tg-felg-T92494-Ab-2Anti-Feline eEF-2K/EEF2K monoclonal antibodyFeline
GM-Tg-cang-T92494-Ab-1/ GM-Tg-cang-T92494-Ab-2Anti-Canine eEF-2K/EEF2K monoclonal antibodyCanine
GM-Tg-bovg-T92494-Ab-1/ GM-Tg-bovg-T92494-Ab-2Anti-Bovine eEF-2K/EEF2K monoclonal antibodyBovine
GM-Tg-equg-T92494-Ab-1/ GM-Tg-equg-T92494-Ab-2Anti-Equine eEF-2K/EEF2K monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T92494-Ab-1/ GM-Tg-hg-T92494-Ab-2; GM-Tg-rg-T92494-Ab-1/ GM-Tg-rg-T92494-Ab-2;
GM-Tg-mg-T92494-Ab-1/ GM-Tg-mg-T92494-Ab-2; GM-Tg-cynog-T92494-Ab-1/ GM-Tg-cynog-T92494-Ab-2;
GM-Tg-felg-T92494-Ab-1/ GM-Tg-felg-T92494-Ab-2; GM-Tg-cang-T92494-Ab-1/ GM-Tg-cang-T92494-Ab-2;
GM-Tg-bovg-T92494-Ab-1/ GM-Tg-bovg-T92494-Ab-2; GM-Tg-equg-T92494-Ab-1/ GM-Tg-equg-T92494-Ab-2
Products NameAnti-eEF-2K/EEF2K monoclonal antibody
Formatmab
Target NameeEF-2K
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-eEF-2K monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T92494-Ag-1Recombinant multi-species EF2K/ eEF-2K/ EEF2K protein
    ORF Viral VectorvGMAP000137Human EEF2K Adenovirus particle
    ORF Viral VectorpGMAP000137Human EEF2K Adenovirus plasmid


    Target information

    Target IDGM-T92494
    Target NameeEF-2K
    Gene ID29904,13631,25435,698604,479812,101101433,521730,100058387
    Gene Symbol and SynonymsCaMKIII,eEF-2K,EEF2K,HSU93850,SMEF2K
    Uniprot AccessionO00418,P70531
    Uniprot Entry NameEF2K_HUMAN,EF2K_RAT
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000103319
    Target ClassificationKinase

    The target: eEF-2K, gene name: EEF2K, also named as CaMKIII, HSU93850, eEF-2K. This gene encodes a highly conserved protein kinase in the calmodulin-mediated signaling pathway that links activation of cell surface receptors to cell division. This kinase is involved in the regulation of protein synthesis. It phosphorylates eukaryotic elongation factor 2 (EEF2) and thus inhibits the EEF2 function. The activity of this kinase is increased in many cancers and may be a valid target for anti-cancer treatment. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.